Ajooni Biotech Limited

NSEI:AJOONI Stok Raporu

Piyasa değeri: ₹1.4b

Ajooni Biotech Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Ajooni Biotech has a total shareholder equity of ₹855.0M and total debt of ₹20.7M, which brings its debt-to-equity ratio to 2.4%. Its total assets and total liabilities are ₹938.3M and ₹83.4M respectively. Ajooni Biotech's EBIT is ₹16.4M making its interest coverage ratio 2.9. It has cash and short-term investments of ₹216.0M.

Anahtar bilgiler

2.4%

Borç/özkaynak oranı

₹20.68m

Borç

Faiz karşılama oranı2.9x
Nakit₹216.04m
Eşitlik₹854.96m
Toplam yükümlülükler₹83.38m
Toplam varlıklar₹938.35m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Ajooni Biotech (NSE:AJOONI) May Have Issues Allocating Its Capital

Oct 11
Ajooni Biotech (NSE:AJOONI) May Have Issues Allocating Its Capital

Ajooni Biotech Limited (NSE:AJOONI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Sep 04
Ajooni Biotech Limited (NSE:AJOONI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Ajooni Biotech Limited's (NSE:AJOONI) 27% Share Price Surge Not Quite Adding Up

Jul 12
Ajooni Biotech Limited's (NSE:AJOONI) 27% Share Price Surge Not Quite Adding Up

Market Cool On Ajooni Biotech Limited's (NSE:AJOONI) Earnings Pushing Shares 25% Lower

Mar 20
Market Cool On Ajooni Biotech Limited's (NSE:AJOONI) Earnings Pushing Shares 25% Lower

We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

Nov 10
We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

Jul 13
We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

If You Like EPS Growth Then Check Out Ajooni Biotech (NSE:AJOONI) Before It's Too Late

Feb 16
If You Like EPS Growth Then Check Out Ajooni Biotech (NSE:AJOONI) Before It's Too Late

Should Weakness in Ajooni Biotech Limited's (NSE:AJOONI) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Feb 14
Should Weakness in Ajooni Biotech Limited's (NSE:AJOONI) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Did Ajooni Biotech Limited (NSE:AJOONI) Insiders Buy Up More Shares?

Dec 24
Did Ajooni Biotech Limited (NSE:AJOONI) Insiders Buy Up More Shares?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: AJOONI's short term assets (₹786.6M) exceed its short term liabilities (₹66.4M).

Uzun Vadeli Yükümlülükler: AJOONI's short term assets (₹786.6M) exceed its long term liabilities (₹17.0M).

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: AJOONI has more cash than its total debt.

Borcun Azaltılması: AJOONI's debt to equity ratio has reduced from 19.2% to 2.4% over the past 5 years.

Borç Kapsamı: AJOONI's operating cash flow is negative, therefore debt is not well covered.

Faiz Kapsamı: AJOONI's interest payments on its debt are not well covered by EBIT (2.9x coverage).

Bilanço

Sağlıklı şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y